Get Started with NeoGenomics
IHC & ISH
NeoTYPE® Cancer Profiles
The introduction of NeoTYPE Broad Reach Tumor Profiles expands on NeoGenomics’ molecular profiling services and enhances ordering flexibility for clients who wish to perform wide-spectrum testing for genomic abnormalities in genes not directly targeted by the NeoTYPE™ Cancer-Specific Profiles. In addition, these profiles can be used for large scale analysis in both hematological and solid tumor cancers.
Using next-gen sequencing as the primary analysis tool in the NeoTYPE® Broad Reach Tumor Profiles, NeoGenomics is able to offer clients the ability to characterize all classes of cancer without compromising the integrity of a patient’s sample. The combination of these four broad reach tumor profiles with the 26 targeted / tumor-specific profiles gives clients a full service menu of molecular profiles to help resolve any diagnostic challenge.
Hematologic Profiles offer a wide-spectrum approach to understanding disease biology and establishes a platform for assessing the diagnosis, determining prognosis, and assisting in the therapy selection process.
NeoTYPE Broad Reach Solid Tumor Profiles are designed to characterize mutations in a large set of genes simultaneously for a variety of solid tumor cancers. The reduced DNA requirements of NGS coordinate well with fine needle biopsy and other minute sample sizes that sometimes limit solid tumor analysis. Options range from the 48-gene Precision Profile, through 315-gene Discovery Profile, to the 4813-gene Cancer Exome Profile.